Health and Life Sciences Committee

Rich Buckley, AstraZeneca -  Chair

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

About BABA

This Committee was created to address the issues associated with the 16% of US GDP devoted to health care, and assess the impact of the newly enacted health care reform law on businesses and individuals. The Committee hopes to provide information related to the expansion of insurance, the creation of new markets and government approaches to the delivery of services and products, and the potential impact on innovation. In addition to health care issues, the committee's focus includes the growing and dynamic field of bioscience technology.

 

Office for Life Sciences EU Exit Bulletin – 4 October 2019

The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS).The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS).The purpose of this bulletin is to provide you with information about the steps that businesses can take to be prepared if the UK leaves the EU without a deal. Please help us reach your suppliers, clients, customers and members by forwarding or sharing the content.